The Innovation Science and Technology Committee (ISTC) at Biolaxygen is a team of top industry experts dedicated to advancing biopharmaceutical innovation.
The committee guides our training and consulting services by tracking emerging trends, shaping cutting-edge programs, and promoting solutions that meet the evolving needs of the industry.
Dr. Paul Liu is a distinguished leader in biopharmaceutical innovation with over three decades of experience spanning process development.
Sunny Tam is a trailblazer in biotechnology and regulatory science, bringing over 20 years of innovation in R&D, assay development, and biomarker discovery to the forefront of the industry.